The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients With Type 1 Diabetes Mellitus Andrea Shin, Michael.

Slides:

Advertisements

Similar presentations

Irritable Bowel Syndrome and Microscopic Colitis: A Systematic Review and Meta- analysis Eline J.C.A. Kamp, John S. Kane, Alexander C. Ford Clinical Gastroenterology.

Advertisements

Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea Banny S. Wong, Michael Camilleri, Paula Carlson, Sanna McKinzie,

Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome–Diarrhea Without Bile Acid Malabsorption Cédric Peleman,

Thrombocytopenia With Abnormal Liver Function Tests

Alan N. Desmond, Sebastian McWilliams, Michael M

Pichamol Jirapinyo, Christopher C. Thompson

Increased Bile Acid Biosynthesis Is Associated With Irritable Bowel Syndrome With Diarrhea Banny S. Wong, Michael Camilleri, Paula Carlson, Sanna McKinzie,

Survival of Patients With Superficial Esophageal Adenocarcinoma After Endoscopic Treatment vs Surgery Saowanee Ngamruengphong, Herbert C. Wolfsen, Michael.

Michael Camilleri, Anthony Lembo, David A. Katzka

Katsunori Matsueda, Tatsuya Toyokawa

A Shocking Cystory Clinical Gastroenterology and Hepatology

Gastric Emptying Clinical Gastroenterology and Hepatology

A Prospective, Randomized Trial of Clear Liquids Versus Low-Fat Solid Diet as the Initial Meal in Mild Acute Pancreatitis Brian C. Jacobson, Martha B.

Effect of Alvimopan and Codeine on Gastrointestinal Transit: A Randomized Controlled Study Jonathan Gonenne, Michael Camilleri, Irene Ferber, Duane Burton,

A Stable Isotope Breath Test With a Standard Meal for Abnormal Gastric Emptying of Solids in the Clinic and in Research Lawrence A. Szarka, Michael Camilleri,

Right Upper Quadrant Pain and a Normal Abdominal Ultrasound

Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis Anita Sainsbury, David S. Sanders, Alexander C.

Volume 139, Issue 5, Pages e1 (November 2010)

Liver Cirrhosis Is Associated With Venous Thromboembolism Among Hospitalized Patients in a Nationwide US Study Harry Wu, Geoffrey C. Nguyen Clinical.

Patient-Reported Outcome Measures for Use in Clinical Trials and Clinical Practice in Inflammatory Bowel Diseases: A Systematic Review Marin J. de Jong,

Diffuse Gastric Wall Thickening: Appearances Can Be Deceptive

Prospective Study of Motor, Sensory, Psychologic, and Autonomic Functions in Patients With Irritable Bowel Syndrome Michael Camilleri, Sanna McKinzie,

Judy A. Trieu, Mohammad Bilal, Ali Hashmi

Relamorelin Relieves Constipation and Accelerates Colonic Transit in a Phase 2, Placebo-Controlled, Randomized Trial Andres Acosta, Michael Camilleri,

Should the Reflex Be Reflux

Volume 131, Issue 6, Pages (December 2006)

Metoclopramide Nasal Spray Reduces Symptoms of Gastroparesis in Women, but not Men, With Diabetes: Results of a Phase 2B Randomized Study Henry P. Parkman,

Talya Salz, Robert S. Sandler Clinical Gastroenterology and Hepatology

Gut Transit Is Associated With Gastrointestinal Symptoms and Gut Hormone Profile in Patients With Cirrhosis Evangelos Kalaitzakis, Riadh Sadik, Jens.

Effect of Gastric Volume or Emptying on Meal-Related Symptoms After Liquid Nutrients in Obesity: A Pharmacologic Study Silvia Delgado–Aros, Michael Camilleri,

Pancreatic Duct Drainage for the Treatment of a Huge Pancreatic Cyst Associated With Autoimmune Pancreatitis Hiroyuki Matsubayashi, Toru Matsui, Hiroyuki.

Functional Dyspepsia Is Associated With Sleep Disorders

Activity-Based Costing and Management in a Hospital-Based GI Unit

Michael Hjelkrem, Joel Stengel, Mark Liu, David P. Jones, Stephen A

AGA Clinical Practice Update on Functional Gastrointestinal Symptoms in Patients With Inflammatory Bowel Disease: Expert Review Jean-Frederic Colombel,

Michael Camilleri, C. Mel Wilcox, Hashem B. El-Serag, Fasiha Kanwal

Volume 149, Issue 2, Pages e2 (August 2015)

Dietary Triggers of Abdominal Symptoms in Patients With Irritable Bowel Syndrome: Randomized Placebo-Controlled Evidence Susan J. Shepherd, Francis C.

Thurarshen Jeyalingam, Yuto Shimamura, Christopher Teshima

Volume 119, Issue 1, Pages (July 2000)

New Models of Gastroenterology Practice

Dushyant Singh, Reetu Singh, Wendell K. Clarkston

Mark Topazian, Michael Camilleri, Felicity T. Enders, Jonathan E

Volume 141, Issue 5, Pages e7 (November 2011)

Prednisolone and Budesonide for Short- and Long-Term Treatment of Microscopic Colitis: Systematic Review and Meta-analysis Michael J. Stewart, Cynthia.

Jagpal S. Klair, Mohit Girotra, Rayburn F. Rego

Volume 148, Issue 3, Pages e4 (March 2015)

Volume 131, Issue 5, Pages (November 2006)

Effect of renzapride on transit in constipation-predominant irritable bowel syndrome Michael Camilleri, Sanna McKinzie, Jean Fox, Amy Foxx-orenstein,

Effects of Different Coping Strategies on Physical and Mental Health of Patients With Irritable Bowel Syndrome Lilian Dindo, PhD Clinical Gastroenterology.

Alan Bonder, MD, Nezam H. Afdhal, MD

The Utility of Intraluminal Impedance in Patients With Gastroesophageal Reflux Disease–Like Symptoms But Normal Endoscopy and 24-Hour pH Testing Michael.

Epidemiology, Mechanisms, and Management of Diabetic Gastroparesis

Nicolas Williet, William J. Sandborn, Laurent Peyrin–Biroulet

Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function Suwebatu T. Odunsi–Shiyanbade, Michael.

Issue Highlights Clinical Gastroenterology and Hepatology

Hepatic Cyst? Clinical Gastroenterology and Hepatology

Thrombocytopenia With Abnormal Liver Function Tests

Alteration of Gastric Functions and Candidate Genes Associated With Weight Reduction in Response to Sibutramine Maria I. Vazquez Roque, Michael Camilleri,

Predictors of Early Treatment Discontinuation Among Patients With Genotype 1 Hepatitis C and Implications for Viral Eradication Lauren A. Beste, George.

A 27-Year-Old Woman With Constipation: Diagnosis and Treatment

Issue Highlights Clinical Gastroenterology and Hepatology

Effects of Chenodeoxycholate and a Bile Acid Sequestrant, Colesevelam, on Intestinal Transit and Bowel Function Suwebatu T. Odunsi–Shiyanbade, Michael.

Chun-Hua Zhou, Wei-Xia Zhou, Duan-Min Hu

Rintaro Hashimoto, Akimichi Chonan

Adverse Outcomes: Why Bad Things Happen to Good People

M. Babitha Reddy, David M. Poppers, Cora Uram–Tuculescu

Rintaro Hashimoto, Akimichi Chonan

Subcapsular Hepatic Fluid Collection Caused by Cardiac Dysfunction

Choosing Wisely and the Perceived Drivers of Endoscopy Use

Presentation transcript:

The Ghrelin Agonist RM-131 Accelerates Gastric Emptying of Solids and Reduces Symptoms in Patients With Type 1 Diabetes Mellitus Andrea Shin, Michael Camilleri, Irene Busciglio, Duane Burton, Steven A. Smith, Adrian Vella, Michael Ryks, Deborah Rhoten, Alan R. Zinsmeister Clinical Gastroenterology and Hepatology Volume 11, Issue 11, Pages 1453-1459.e4 (November 2013) DOI: 10.1016/j.cgh.2013.04.019 Copyright © 2013 AGA Institute Terms and Conditions

Figure 1 Patient disposition using the consolidated standards of reporting trials (CONSORT) approach. All participants completed all studies, and data were analyzed using intention-to-treat principles. Clinical Gastroenterology and Hepatology 2013 11, 1453-1459.e4DOI: (10.1016/j.cgh.2013.04.019) Copyright © 2013 AGA Institute Terms and Conditions

Figure 2 Changes in GE t1/2 solids by treatment period for each patient (GE, minutes for solids for all 10 patients by treatment period: placebo and RM-131). Data are individual observations for each patient. The published median (83 min) and IQR (64–103 min) from 123 healthy volunteers using the identical radiolabeled meal are presented.16 Clinical Gastroenterology and Hepatology 2013 11, 1453-1459.e4DOI: (10.1016/j.cgh.2013.04.019) Copyright © 2013 AGA Institute Terms and Conditions

Figure 3 Effect of RM-131 on main transit measurements in all 10 participants (GE, minutes for solids and liquids [A]; percentage GE at 1, 2, and 4 hours, and CF6 at 6 hours [B]). Gray, placebo; white, RM-131 100 μg. Data are median (IQR and range); P values by Wilcoxon signed-rank test or paired t test (for GE 1 hour and 2 hour) comparing RM-131 versus placebo. Δ, median percentage difference for each end point. Data were not available for 1 participant for GE 1 hour. NS, not significant. Clinical Gastroenterology and Hepatology 2013 11, 1453-1459.e4DOI: (10.1016/j.cgh.2013.04.019) Copyright © 2013 AGA Institute Terms and Conditions

Figure 4 Assessment of GE of solids by scintigraphy in 1 patient showing DGE with placebo and normal GE with RM-131 (A). GE is shown as the percentage emptied over time for placebo and RM-131 in the same individual (B). Clinical Gastroenterology and Hepatology 2013 11, 1453-1459.e4DOI: (10.1016/j.cgh.2013.04.019) Copyright © 2013 AGA Institute Terms and Conditions